Assessing Developability of Novel Biotherapeutics Through Mass Spectrometry Background Numerous characteristics—such as potency and efficacy, consistent manufacturability, physical and chemical stability, and safety—must be considered when developing biotherapeutics. For biopharma companies, identifying and understanding the risk factors inherent to drug candidate development is crucial to implementing effective and timely mitigation strategies. Novel biotherapeutic constructs are becoming more prevalent in discovery and development pipelines and their complexity results in an increasing need for faster and better characterization tools to identify the key parameters that influence a candidate’s potency and physicochemical properties. To better identify the most promising drug can

Join for free to read